Elotuzumab, pomalidomide, and dexamethasone is a very well tolerated regimen associated with durable remission even in very advanced myeloma: a retrospective study from two academic centers (2021) Hose D, Schreder M, Hefner J, Bittrich M, Danhof S, Strifler S, Krauth MT, et al. Journal article Inflammatory markers in autoimmunity induced by checkpoint inhibitors (2021) Husain B, Kirchberger M, Erdmann M, Schüpferling S, Abolhassani AR, Fröhlich W, Berking C, Heinzerling L Journal article Identification of oral squamous cell carcinoma markers MUC2 and SPRR1B downstream of TANGO (2021) Sasahira T, Kurihara-Shimomura M, Shimomura H, Boßerhoff AK, Kirita T Journal article Sentinel lymph node detection by means of indocyanine green using the Karl Storz VITOM® fluorescence camera: a comparison between primary sentinel lymph node biopsy versus sentinel lymph node biopsy after neoadjuvant chemotherapy (2020) Staubach P, Scharl A, Ignatov A, Ortmann O, Inwald EC, Hildebrandt T, Gerken M, et al. Journal article Patterns of care and follow-up care of patients with uveal melanoma in German-speaking countries: a multinational survey of the German Dermatologic Cooperative Oncology Group (DeCOG) (2020) Steeb T, Wessely A, Alter M, Bayerl C, Bender A, Bruning G, Dabrowski E, et al. Journal article Guidelines for uveal melanoma: a critical appraisal of systematically identified guidelines using the AGREE II and AGREE-REX instrument (2020) Steeb T, Hayani KM, Förster P, Liegl R, Toussaint F, Schlaak M, Berking C, Heppt M Journal article Long-term outcome of patients with intermediate- and high-risk endometrial cancer after pelvic and paraaortic lymph node dissection: a comparison of laparoscopic vs. open procedure (2020) Papathemelis T, Oppermann H, Grafl S, Gerken M, Pauer A, Scharl S, Scharl A, et al. Journal article C-reactive protein as an early marker of immune-related adverse events (2019) Abolhassani AR, Schuler G, Kirchberger MC, Heinzerling L Journal article A three-gene methylation marker panel for the nodal metastatic risk assessment of muscle-invasive bladder cancer (2019) Stubendorff B, Wilhelm K, Posselt K, Catto J, Hartmann A, Bertz S, Fuessel S, et al. Journal article Clinical and biological characteristics of myeloma patients influence response to elotuzumab combination therapy (2019) Danhof S, Strifler S, Hose D, Kortuem M, Bittrich M, Hefner J, Einsele H, et al. Journal article